05/03/2019
3:10 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
10:47 AM | Argos Therapeutics (Subject)
ForArgos B.V. (Filed by)
| Form SC 13D/A
| |
12/03/2018
7:01 AM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2018
2:13 PM | Argos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2018
1:49 PM | Argos Therapeutics (Filer)
| Form NT 10-Q
| |
08/20/2018
3:55 PM | Argos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2018
6:00 AM | Argos Therapeutics (Filer)
| Form NT 10-Q
| |
07/20/2018
3:30 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2018
8:04 AM | Argos Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
05/15/2018
4:01 PM | Argos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
05/15/2018
3:47 PM | Argos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2018
11:25 AM | Argos Therapeutics (Filer)
| Form CT ORDER
| |
04/25/2018
3:59 PM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2018
3:58 PM | Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2018
3:58 PM | Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2018
3:57 PM | Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2018
4:29 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
7:05 AM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2018
4:06 PM | Argos Therapeutics (Filer)
| Form 424B5
| |
04/02/2018
1:13 PM | Argos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/02/2018
8:48 AM | Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
7:45 AM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/30/2018
4:14 PM | Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2018
4:13 PM | Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2018
4:12 PM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
3:31 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2018
7:30 AM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2018
3:57 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2018
11:15 PM | Argos Therapeutics (Filer)
| Form EFFECT
| |
01/18/2018
12:20 PM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2018
9:44 AM | Argos Therapeutics (Filer)
| Form CT ORDER
| |
01/17/2018
9:41 AM | Argos Therapeutics (Filer)
| Form CT ORDER
| |
01/12/2018
2:21 PM | Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
| Form 4/A
| |
01/12/2018
2:17 PM | Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
| Form 4/A
| |
01/12/2018
2:13 PM | Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
| Form 4/A
| |
01/12/2018
1:35 PM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4/A
| |
01/12/2018
1:01 PM | Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2018
12:55 PM | Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2018
12:48 PM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2018
12:41 PM | Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
7:40 AM | Argos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2018
11:27 AM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2018
11:12 AM | Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2018
11:04 AM | Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2018
10:56 AM | Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2018
10:46 AM | Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2018
3:31 PM | Argos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
